Exar Corp. (EXAR) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts EXAR Hot Sheet
Price: $12.99 --0%
Financial Fact:
Research and development: 4.95M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 4.95M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Exar Corp. (NYSE: EXAR) reported Q2 EPS of $0.05, in-line with the analyst estimate of $0.05. Revenue for the quarter came in at $43.16 million versus the consensus estimate of $43.2 million.
Exar Corp. sees Q3 2014 EPS of $0.04-$0.06, versus the consensus of $0.07.
For earnings history and earnings-related data on Exar Corp. (EXAR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
